Search Results - "Dominick, J"

Novel antiplatelet agents in acute coronary syndrome by Franchi, Francesco, Angiolillo, Dominick J.

“…Key Points Platelet adhesion, activation, and aggregation after plaque rupture or erosion are the major determinants of arterial thrombosis leading to acute…”
Get full text

Management of Antiplatelet Therapy After Coronary Stenting in Patients Requiring Noncardiac Surgery by Angiolillo, Dominick J.

Get full text

Guided versus standard antiplatelet therapy in patients undergoing percutaneous coronary intervention: a systematic review and meta-analysis by Galli, Mattia, Benenati, Stefano, Capodanno, Davide, Franchi, Francesco, Rollini, Fabiana, D'Amario, Domenico, Porto, Italo, Angiolillo, Dominick J

“…Whether guided selection of antiplatelet therapy in patients undergoing percutaneous coronary intervention (PCI) is effective in improving outcomes compared…”
Get full text

Aspirin for Primary Cardiovascular Risk Prevention and Beyond in Diabetes Mellitus by Capodanno, Davide, Angiolillo, Dominick J

“…Daily administration of low-dose aspirin has proved to be beneficial in preventing recurrent cardiovascular events. However, the role of aspirin for primary…”
Get full text

ACC/AHA Versus ESC Guidelines on Dual Antiplatelet Therapy: JACC Guideline Comparison by Capodanno, Davide, Alfonso, Fernando, Levine, Glenn N, Valgimigli, Marco, Angiolillo, Dominick J

“…Dual antiplatelet therapy (DAPT) is the cornerstone of pharmacological treatment aimed at preventing the atherothrombotic complications in patients with a…”
Get full text

Dual antiplatelet therapy guided by platelet function testing by Angiolillo, Dominick J

“…Oral P2Y12 receptor inhibitors are key for secondary prevention of atherothrombotic events in patients with acute coronary syndromes, in particular those…”
Get full text

Switching P2Y12-receptor inhibitors in patients with coronary artery disease by Rollini, Fabiana, Franchi, Francesco, Angiolillo, Dominick J.

“…Key Points Dual antiplatelet therapy with aspirin and a P2Y 12 -receptor inhibitor is the cornerstone of treatment of patients with acute coronary syndromes…”
Get full text

Timing, Selection, Modulation, and Duration of P2Y12 Inhibitors for Patients With Acute Coronary Syndromes Undergoing PCI by Capodanno, Davide, Angiolillo, Dominick J.

Get full text

Personalised antiplatelet therapies for coronary artery disease: what the future holds by Capodanno, Davide, Angiolillo, Dominick J

“…Abstract Coronary artery disease (CAD) is one of the leading causes of death globally, and antiplatelet therapy is crucial for both its prevention and…”
Get full text

Antithrombotic Therapy for Atherosclerotic Cardiovascular Disease Risk Mitigation in Patients With Coronary Artery Disease and Diabetes Mellitus by Capodanno, Davide, Angiolillo, Dominick J.

“…Patients with diabetes mellitus (DM) are characterized by enhanced thrombotic risk attributed to multiple mechanisms including hyperreactive platelets,…”
Get full text

Coronavirus Disease 2019-Associated Thrombosis and Coagulopathy: Review of the Pathophysiological Characteristics and Implications for Antithrombotic Management by Ortega-Paz, Luis, Capodanno, Davide, Montalescot, Gilles, Angiolillo, Dominick J

“…Coronavirus disease 2019 (COVID-19) is an infectious disease caused by severe acute respiratory syndrome coronavirus-2, which has posed a significant threat to…”
Get full text

Antithrombotic therapy for patients with STEMI undergoing primary PCI by Franchi, Francesco, Rollini, Fabiana, Angiolillo, Dominick J.

“…Key Points Antithrombotic therapy is the cornerstone of pharmacological treatment to optimize clinical outcomes in patients with ST-segment elevation…”
Get full text

Aspirin for Primary Prevention of Cardiovascular Disease in the 21st Century: A Review of the Evidence by Angiolillo, Dominick J, Capodanno, Davide

“…Aspirin (ASA) is the most commonly prescribed antiplatelet agent. Although the evidence for efficacy of aspirin for secondary prevention of ischemic events in…”
Get full text

Optimal antiplatelet therapy in patients at high bleeding risk undergoing complex percutaneous coronary intervention by Ortega-Paz, Luis, Angiolillo, Dominick J

Get full text

The Evolution of Antiplatelet Therapy in the Treatment of Acute Coronary Syndromes: From Aspirin to the Present Day by Angiolillo, Dominick J.

“…Our knowledge of the mechanisms of platelet-mediated thrombosis has increased dramatically over the last 40 years. This increased understanding has identified…”
Get full text

Antithrombotic Management of Elderly Patients With Coronary Artery Disease by Capranzano, Piera, Angiolillo, Dominick J.

“…Antithrombotic therapy represents the mainstay of treatment in patients with coronary artery disease (CAD), including elderly patients who are at increased…”
Get full text

Tailoring duration of DAPT with risk scores by Capodanno, Davide, Angiolillo, Dominick J

“…[...]because risk factors for ischaemia and bleeding largely overlap, modelling of such an algorithm is challenging. [...]a risk model should be both precise…”
Get full text

Updated Expert Consensus Statement on Platelet Function and Genetic Testing for Guiding P2Y12 Receptor Inhibitor Treatment in Percutaneous Coronary Intervention by Sibbing, Dirk, Aradi, Daniel, Alexopoulos, Dimitrios, ten Berg, Jurrien, Bhatt, Deepak L., Bonello, Laurent, Collet, Jean-Philippe, Cuisset, Thomas, Franchi, Francesco, Gross, Lisa, Gurbel, Paul, Jeong, Young-Hoon, Mehran, Roxana, Moliterno, David J., Neumann, Franz-Josef, Pereira, Naveen L., Price, Matthew J., Sabatine, Marc S., So, Derek Y.F., Stone, Gregg W., Storey, Robert F., Tantry, Udaya, Trenk, Dietmar, Valgimigli, Marco, Waksman, Ron, Angiolillo, Dominick J.

“…Dual-antiplatelet therapy (DAPT) with aspirin and a P2Y12 receptor inhibitor is the standard treatment for patients undergoing percutaneous coronary…”
Get full text

Validation of the Academic Research Consortium High Bleeding Risk Definition in Contemporary PCI Patients by Cao, Davide, Mehran, Roxana, Dangas, George, Baber, Usman, Sartori, Samantha, Chandiramani, Rishi, Stefanini, Giulio G, Angiolillo, Dominick J, Capodanno, Davide, Urban, Philip, Morice, Marie-Claude, Krucoff, Mitchell, Goel, Ridhima, Roumeliotis, Anastasios, Sweeny, Joseph, Sharma, Samin K, Kini, Annapoorna

“…Bleeding following percutaneous coronary intervention has important prognostic implications. The Academic Research Consortium (ARC) recently proposed a list of…”
Get full text

Long-Term P2Y 12 Inhibitor or Aspirin as Single Antiplatelet Therapy in Patients With Previous Percutaneous Coronary Intervention by Capodanno, Davide, Angiolillo, Dominick J

Get full text